Report on the PQRI impurity characterization and quantification best practices survey.
Food and Drug Administration, Rockville, Maryland, USA. faustinop@cder.fda.gov
P
P
Faustino
C C
CC
Chan
J
J
Carrano
M
M
Gosnell
Z Q
ZQ
Gu
A
A
Maule
K
K
Sigvardson
Y F
YF
Zhang
D004339:Drug Compounding / Q000592:standards*; D004340:Drug Contamination; D004345:Drug Industry / Q000592:standards*; D004364:Pharmaceutical Preparations / Q000032:analysis / Q000592:standards*; D010602:Pharmacopoeias as Topic; D011786:Quality Control; D015203:Reproducibility of Results; D013056:Spectrophotometry, Ultraviolet; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations